ReviewCognitive behaviour therapy2026
The role of distress tolerance in treatment of posttraumatic stress and substance use disorders: a systematic review.
Review in Cognitive behaviour therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Comorbid posttraumatic stress disorder and substance use disorder (PTSD-SUD) is associated with more severe symptoms, higher treatment dropout, and worse treatment outcomes than either condition alone. Distress tolerance (DT) is a potentially modifiable risk factor of PTSD and SUD that may impact treatment outcomes. However, little is known about changes in or impact of DT on comorbid PTSD-SUD treatment. This review identified treatment outcome studies of adult samples with SUD and diagnosis or symptoms of comorbid PTSD that examined the assessment of DT and its effects on treatment. Eight articles representing seven unique studies were included. No study included DT-specific interventions for PTSD and/or SUD, and only three examined change in DT over the course of treatment. Most studies examined DT as a predictor of premature treatment discontinuation or a baseline predictor of treatment outcomes. Though DT was not a robust predictor of treatment discontinuation and results were inconsistent on SUD outcomes, lower levels of DT predicted slower or less symptom improvement in PTSD. Future work should address DT in comorbid PTSD-SUD, identify active ingredients of current empirically supported treatments for PTSD and/or SUD, and incorporate additional DT skills into existing treatments, particularly for clients with low DT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.